Skin decontamination of Carfentanil in vitro.

Carfentanil Diffusion cell Opioid Percutaneous penetration Skin decontamination

Journal

Toxicology letters
ISSN: 1879-3169
Titre abrégé: Toxicol Lett
Pays: Netherlands
ID NLM: 7709027

Informations de publication

Date de publication:
01 Oct 2023
Historique:
received: 17 08 2023
revised: 28 09 2023
accepted: 05 10 2023
medline: 6 11 2023
pubmed: 9 10 2023
entrez: 8 10 2023
Statut: ppublish

Résumé

Skin decontamination of Chemical Biological Radioactive and Nuclear (CBRN) materials involves the timely and effective removal of the contaminants from the skin surface. The current work evaluated Fuller's Earth & The Reactive Skin Decontaminant Lotion Kit (RSDL®) to investigate whether they were as efficacious against free base Carfentanil skin contamination as they are against chemical warfare agents. The in vitro methodology used allowed for evaluation of decontamination regimens as specified by the decontaminant manufacturer rather than as an application of a bolus dose left in situ for the study duration. A selection of novel decontaminants, including Dermal Decontamination Gel (DDGel), Trivorex®, itaconic acid (IA), N,N'-methylenebisacrylamide (MBA), 2-trifluoromethylacrylic acid (TFMAA) and NanoSan Sorb were also tested for efficacy. All the evaluated decontaminants were successful at removing the majority of the Carfentanil skin surface contamination. The current work has shown that the Fuller's Earth decontamination kit, removes as much (or more) free base carfentanil from the skin surface in comparison to other products tested in this study series.

Identifiants

pubmed: 37806367
pii: S0378-4274(23)01060-3
doi: 10.1016/j.toxlet.2023.10.005
pii:
doi:

Substances chimiques

Fuller's Earth 8031-18-3
carfentanil LA9DTA2L8F
Chemical Warfare Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

56-63

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Christopher Dalton (C)

Chemical Biological and Radiological Division, Dstl Porton Down, Salisbury SP4 0JQ, UK. Electronic address: chdalton@dstl.gov.uk.

Rachel Watkins (R)

Chemical Biological and Radiological Division, Dstl Porton Down, Salisbury SP4 0JQ, UK.

Sarah Pritchard (S)

Chemical Biological and Radiological Division, Dstl Porton Down, Salisbury SP4 0JQ, UK.

Stuart Graham (S)

Chemical Biological and Radiological Division, Dstl Porton Down, Salisbury SP4 0JQ, UK.

Articles similaires

Aerosols Humans Decontamination Air Microbiology Masks
Humans Psoriasis Lipocalin-2 Keratinocytes Calgranulin B

Classifications MeSH